Outstanding aspartame experts have spoken out against the poison aspartame since the beginning. Today as autism has increased 2500%. the FDA continues to ignore all the records. Read how G. D. Searle made a deal with the FDA to seal the teratology studies so the public wouldn't know aspartame triggers birth defects http://www.rense.com/general96/asparautism.html
This chapter on autism is from the medical text on aspartame and methanol, "While Science Sleeps: A Sweetener Kills" by Dr. Woodrow Monte. The report below needs to be added to many web sites to alert pregnant women to never use aspartame. The original studies sealed from the records by FDA for decades showed neural tube defects, spina bifida and cleft palate for starters! See the Bressler Report http://www.mpwhi.com/complete_bressler_report.pdf to read the FDA records they tried to hide from public view.
EMORY UNIVERSITY SCHOOL OF MEDICINE
DEPARTMENT OF PEDIATRICS
2040 Ridgewood Drive, N.E. Atlanta, Georgia 30322
Division of MEDICAL GENETICS
Statement for the Labor and Human Resources Committee, U.S. Senate
I have considerable concern for the increased dissemination and consumption of the sweetener, aspartame, (1-methyl N-L-a-aspartyl-L-phenylalanine) in our world food supply. This artificial dipeptide is hydrolyzed by the intestinal tract to produce L-phenylalanine which in excess is a known neurotoxin. Normal humans do not metabolize phenylalanine as efficiently as do lower species such as rodents and thus most of the previous studies in Aspartame effects on rats are irrelevant to the question, "does phenylalanine excess occur with Aspartame ingestion?".
Preliminary studies in my laboratory provide tentative positive answers to both questions. Many studies of both acute and chronic ingestion of 34mg Aspartame/kg/day have demonstrated a two to five fold increase in semi-fasting blood phenylalanine concentrations (from approximately 50 to 250 M) without concomitant increases in tyrosine or other aminoacids. The degree of increase by normal humans depends on several variables including the efficiency of tut transport, liver utilization, and growth rates. It was thought by many scientists and clinicians that this degree of phenylalanine increase would not affect brain function. However, currently available information indicates that this is not true.
Louis J. Elsas, II, M.D.
Director, Division of Medical Genetics
Professor of Pediatrics
The above statement was before the Committee of Labor and Human Resources on the subject "Nutrasweet: Health and safety concerns", and dated November 3, 1987.